Purpose of the development: Bones and treatment of the musculoskeletal system.

Recommended application field: Medicine-Surgery.

Advantages over analogues: Composition "Levkin" significantly accelerates bone regeneration in combination with a graft.

The development stage readiness: Ready for application

Description of the development:
()
The polymer composition "Levkin" is used in the treatment of the musculoskeletal system in tumor processes. It has a local anti-cancer, anti-inflammatory and regenerative effect. Composition "Levkin" significantly accelerates bone regeneration in combination with a graft. Process resorption polymeric drug in the body in parallel with the process of bone formation, and thus provides fort contact bone graft, bone patient, which significantly reduces the number of postoperative complications. The set of resin compositions "Levkin" includes three components: oligouretandiizotsionat, 2,4,6-tris (dimethylaminomethyl) phenol, and levamisole.   Designed drug was tested at the Research Institute of Oncology and Radiology of Ukraine. This product is protected by patents: Patent number 1637647 USSR, Ukraine patent - a priority. Number 93030244. This development is needed to address the problem of providing health care drugs for the treatment of the musculoskeletal system.

Information about newness of the development:
there are Ukrainian patents -- 2 items

Possibility of transfer abroad:
Licence's sale
Creation of joint enterprise

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua